The most commonly reported side effects in clinical trials are nausea, vomiting, diarrhoea, and constipation consistent with the gastrointestinal effects seen with GLP-1 monotherapy
Professional lab testing, consultations, and ongoing medical monitoring also play a role, which is why costs can vary so much
Rare hypersensitivity reactions can occur and could theoretically present with lymphadenopathy
The ProtecT trial randomised 1,643 patients to active treatment (RP or RT) or active monitoring for localised PCa and assessed sexual function, including EF, using the EPIC-26 instrument [286]
An update on the genetics, clinical presentation, and pathomechanisms of human riboflavin transporter deficiency